Back to search

Article

Dihydroartemisinin downregulates the expression of COX-2 in esophageal squamous cell carcinoma through ROS/MAPK/Sp1 axis

2025-11-10

Abstract excerpt

<title>Abstract</title> <p>Background Esophageal squamous cell carcinoma (ESCC) is associated with a poor clinical prognosis due to its highly invasive and metastatic characteristics, as well as chemotherapy resistance, highlighting an urgent need to explore novel therapeutic targets and drugs. Dihydroartemisinin (DHA), a derivative of artemisinin, has been demonstrated to possess broad anti-tumor activity, while...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
a5f7343d-969f-5d32-91f9-4ac48dace85d
DOI
10.21203/rs.3.rs-7882728/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Dihydroartemisinin downregulates the expression of COX-2 in esophageal squamous cell carcinoma through ROS/MAPK/Sp1 axisDOI 10.21203/rs.3.rs-7882728/v1
Select a neighboring publication to make it the new centre.